argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets to treat diseases with significant unmet...

AstraZeneca We are building out a best-in-class Regulatory Science team to support R&D as well as digital solutions including digital therapeutics, which will be part of the future of measurement science and analytics to support novel endpoints/interventions. Evinova is a health-tech business, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigour, and human experience-driven insight, our digital solutions are deliberately designed so that everyone can reach better health outcomes together. Evinova is a health-tech business within the AstraZeneca Group. At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate,...

AstraZeneca Do you have expertise in, and curiosity for leading Medical Affairs teams in Oncology ? Apply your experience to changing the way cancer is treated at AstraZeneca , a company that follows the science and turns ideas into life changing medicines. Help to advance our incredible pipeline by applying expertise and accelerating our pathway to finding a cure. A dedicated Oncology Business Unit (OBU), this is the place to build a best-in-class career. AstraZeneca's vision in Oncology is to help patients by redefining the cancer-treatment paradigm with the bold ambition to eliminate cancer as a cause of death. We are proud to work on ground-breaking science with one of the broadest and deepest Oncology pipelines in the business. Reporting to the Medical Head, the US Oncology Medical Affairs Group Medical Lead plays a pivotal role in channelling our scientific capabilities and strategy to make a positive impact on changing patients' lives. Join us at our dynamic site...

Site Name: UK - London - New Oxford Street, USA - Pennsylvania - Upper Providence Posted Date: Sep 27 2024 Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Belimumab For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our...

Biogen Job Description Medical Director, US Medical Affairs, Alzheimer's (Specialty Care) About This Role The Medical Director - Alzheimer's role is a part of Specialty Care, North America (US) Medical, a strategic partner within Biogen, that helps inform medical practice across our therapeutic areas and pipeline to improve meaningful patient outcomes. As a key member of the US Specialty Care Medical Director office team reporting to the Head of Medical Director Office, the Medical Director - Alzheimer's is the medically accountable lead for supporting the development and implementation of the US Medical Strategy for Alzheimer's. Biogen's priority is to continue to foster and enable a diverse and inclusive workforce - representing age, gender, sexual identity, race, ethnicity, Veterans, and people with disabilities - that reflects the communities where we operate and the patients who we serve.   This position can be on campus or hybrid in the Cambridge area.   What...

GSK GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world. At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity. The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of...

GSK For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with them to ensure we are generating value evidence data that includes real world evidence and cost...

GSK GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world. At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity. The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of...

GSK GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world. At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity. The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Herpes zoster For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - RSV For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with them...

GSK GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world. At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity. The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Pneumococcal MAPS For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Belimumab For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with...

GSK GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world. At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity. The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of...